SHANGHAI (Reuters). Three Chinese companies – an engineer machinery manufacturer, a battery producer, and a medical device manufacturer – announced Wednesday plans to list on SIX Swiss Exchange. Beijing is reaffirming its support of offshore listings.

Shanghai-listed Sany Heavy Industry Co. Shenzhen-traded Gotion High Tech Co. Lepu Medical Technology, (Beijing) Co. stated in respective filings that their goal is to sell Global Depository Receipts from Switzerland to help fund global expansion.

These companies stated they also answered government calls for connectivity between European and Chinese capital market. They added that listing offshore would allow them to expand financing options and enhance corporate governance.

China enlarged its stock connection scheme connecting Shanghai and London late last year to incorporate capital markets from Germany and Switzerland. [L1N2T20WA]

First batch of applications under expanded scheme is now open. Chinese vice premier Liu He announced Wednesday that China continues to support domestic listings through offshore listing.

China’s securities regulator also pledged Wednesday that it would keep international listing channels open. This is part of an effort to placate investors concerned about possible financial decoupling in the midst of increased geopolitical tensions between Beijing, Washington.

Alternative offshore listings venues are available in Europe for Chinese companies that do not reside in the United States or Hong Kong.

Sany is a Chinese major manufacturer of construction and mining machinery. A listing on the Swiss Exchange would allow it to accelerate internationalization and make it more competitive.

Sany stated that the company hopes to fully benefit from China’s capital market reforms and strong support for connecting directly to overseas capital markets.

Gotion is a manufacturer of lithium-ion battery power batteries for electric cars and has Volkswagen AG (OTC) listed as a strategic partner. It said that it would use the profits from the planned listing in order to finance global expansion.

Lepu Medical stated that listing abroad will increase its market share and global brand.

Each of the three companies indicated that they are currently discussing their fundraising plans and that approvals from regulators and shareholders is required for the issuance.